These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23285299)

  • 21. Limited prevalence of influenza A/H1N1v antibodies: footprints of the pandemic of 2010.
    Reinheimer C; Allwinn R; Doerr HW
    Infection; 2011 Apr; 39(2):101-4. PubMed ID: 21424756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-pandemic seroprevalence of pandemic influenza A (H1N1) 2009 infection (swine flu) among children <18 years in Germany.
    von Kries R; Weiss S; Falkenhorst G; Wirth S; Kaiser P; Huppertz HI; Tenenbaum T; Schroten H; Streng A; Liese J; Shai S; Niehues T; Girschick H; Kuscher E; Sauerbrey A; Peters J; Wirsing von König CH; Rückinger S; Hampl W; Michel D; Mertens T
    PLoS One; 2011; 6(9):e23955. PubMed ID: 21915270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-protection to new drifted influenza A(H3) viruses and prevalence of protective antibodies to seasonal influenza, during 2014 in Portugal.
    Guiomar R; Pereira da Silva S; Conde P; Cristóvão P; Maia AC; Pechirra P; Rodrigues AP; Nunes B; ; Milho L; Coelho AP; Fernandes A; Caseiro P; Rodrigues F; Correia L; Pereira-Vaz J; Almeida S; Branquinho P; Côrte-Real R; Viseu R; Peres MJ; Sanches R; Dantas F; Freitas L; Andrade G; Maurílio M; Caldeira F; Cabral Veloso R; Mota-Vieira L; Soares M; Couto AR; Bruges-Armas J; Pinto RM; Sobrinho Simões J; Costa MDR; Guimarães JT; Martins L; Cunha M
    Vaccine; 2017 Apr; 35(16):2092-2099. PubMed ID: 28318771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serological study of the 2009 pandemic due to influenza A H1N1 in the metropolitan French population.
    Delangue J; Salez N; Ninove L; Kieffer A; Zandotti C; Seston M; Lina B; Nougairede A; Charrel R; Flahault A; de Lamballerie X
    Clin Microbiol Infect; 2012 Feb; 18(2):177-83. PubMed ID: 21635661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional and age-specific patterns of pandemic H1N1 influenza virus seroprevalence inferred from vaccine clinical trials, August-October 2009.
    Tsai TF; Pedotti P; Hilbert A; Lindert K; Hohenboken M; Borkowski A; Groth N; da Silva LJ; Kyaw MH
    Euro Surveill; 2010 Jul; 15(30):. PubMed ID: 20684814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The seroprevalence of pandemic influenza H1N1 (2009) virus in China.
    Xu C; Bai T; Iuliano AD; Wang M; Yang L; Wen L; Zeng Y; Li X; Chen T; Wang W; Hu Y; Yang L; Li Z; Zou S; Li D; Wang S; Feng Z; Zhang Y; Yu H; Yang W; Wang Y; Widdowson MA; Shu Y
    PLoS One; 2011 Apr; 6(4):e17919. PubMed ID: 21533034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seroprevalence of influenza A(H1N1)pdm09 virus antibody, England, 2010 and 2011.
    Hoschler K; Thompson C; Andrews N; Galiano M; Pebody R; Ellis J; Stanford E; Baguelin M; Miller E; Zambon M
    Emerg Infect Dis; 2012 Nov; 18(11):1894-7. PubMed ID: 23092684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seroepidemiology of pandemic influenza A (H1N1) 2009 virus infections in Pune, India.
    Tandale BV; Pawar SD; Gurav YK; Chadha MS; Koratkar SS; Shelke VN; Mishra AC
    BMC Infect Dis; 2010 Aug; 10():255. PubMed ID: 20738878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absence of cross-reactive antibodies to influenza A (H1N1) 2009 before and after vaccination with 2009 Southern Hemisphere seasonal trivalent influenza vaccine in children aged 6 months-9 years: a prospective study.
    McVernon J; Laurie K; Barr I; Kelso A; Skeljo M; Nolan T
    Influenza Other Respir Viruses; 2011 Jan; 5(1):7-11. PubMed ID: 21138535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influenza A (H1N1) 2009 antibodies in residents of New South Wales, Australia, after the first pandemic wave in the 2009 southern hemisphere winter.
    Gilbert GL; Cretikos MA; Hueston L; Doukas G; O'Toole B; Dwyer DE
    PLoS One; 2010 Sep; 5(9):e12562. PubMed ID: 20830210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of serum antibodies against swine-origin influenza A virus H1N1/09 by immunofluorescence, haemagglutination inhibition, and by neutralization tests: how is the prevalence rate of protecting antibodies in humans?
    Allwinn R; Geiler J; Berger A; Cinatl J; Doerr HW
    Med Microbiol Immunol; 2010 May; 199(2):117-21. PubMed ID: 20162304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serological analysis of human pandemic influenza (H1N1) in Thailand.
    Prachayangprecha S; Makkoch J; Payungporn S; Chieochansin T; Vuthitanachot C; Vuthitanachot V; Theamboonlers A; Poovorawan Y
    J Health Popul Nutr; 2010 Dec; 28(6):537-44. PubMed ID: 21261198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seroprevalence study in Vojvodina (Serbia) following 2009 pandemic influenza A(H1N1)V.
    Petrović V; Reguljev Z; Nedeljković J; Ristić M
    Srp Arh Celok Lek; 2012; 140(11-12):751-5. PubMed ID: 23350250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved serological response to H1N1 monovalent vaccine associated with viral suppression among HIV-1-infected patients during the 2009 influenza (H1N1) pandemic in the Southern Hemisphere.
    Maruszak H; Jeganathan S; Smith DE; Robertson P; Barnes T; Furner V
    HIV Med; 2012 Jul; 13(6):352-7. PubMed ID: 22296264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determinants of individuals' risks to 2009 pandemic influenza virus infection at household level amongst Djibouti city residents--a CoPanFlu cross-sectional study.
    Andayi F; Crepey P; Kieffer A; Salez N; Abdo AA; Carrat F; Flahault A; de Lamballerie X
    Virol J; 2014 Jan; 11():13. PubMed ID: 24468218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends in seroprevalence of antibodies to pandemic influenza H1N1 (2009) virus among patients seeking care in China.
    Xu C; Bai T; Wang M; Chen T; Wang L; Chen M; Zeng Y; Fan Ch; Yuan F; Shi J; Sun S; Li D; Wang S; Feng Z; Zhang Y; Yu H; Yang W; Wang Y; Shu Y
    Acta Virol; 2012; 56(4):329-35. PubMed ID: 23237089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long term effectiveness of adjuvanted influenza A(H1N1)pdm09 vaccine in children.
    Örtqvist Å; Bennet R; Hamrin J; Rinder MR; Lindblad H; Öhd JN; Eriksson M
    Vaccine; 2015 May; 33(22):2558-61. PubMed ID: 25869891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence and epidemiology of hospitalized influenza cases in rural Thailand during the influenza A (H1N1)pdm09 pandemic, 2009-2010.
    Baggett HC; Chittaganpitch M; Thamthitiwat S; Prapasiri P; Naorat S; Sawatwong P; Ditsungnoen D; Olsen SJ; Simmerman JM; Srisaengchai P; Chantra S; Peruski LF; Sawanpanyalert P; Maloney SA; Akarasewi P
    PLoS One; 2012; 7(11):e48609. PubMed ID: 23139802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between Hemagglutinin Stem-Reactive Antibodies and Influenza A/H1N1 Virus Infection during the 2009 Pandemic.
    Hoa LNM; Mai LQ; Bryant JE; Thai PQ; Hang NLK; Yen NTT; Duong TN; Thoang DD; Horby P; Werheim HFL; Fox A
    J Virol; 2016 Jul; 90(14):6549-6556. PubMed ID: 27170747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection.
    Ahmed MS; Jacques LC; Mahallawi W; Ferrara F; Temperton N; Upile N; Vaughan C; Sharma R; Beer H; Hoschler K; McNamara PS; Zhang Q
    Antiviral Res; 2015 Feb; 114():106-12. PubMed ID: 25513756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.